GlaxoSmithKline Pharmaceuticals Limited Net Asset Momentum
GlaxoSmithKline Pharmaceuticals Limited net asset momentum. GlaxoSmithKline Pharmaceuticals Limited (GLAXO) recorded a net asset momentum of 9.8% as of March 2025, with net assets of Rs19.51 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore GlaxoSmithKline Pharmaceuticals Limited capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Net asset momentum of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. This chart tracks GlaxoSmithKline Pharmaceuticals Limited's year-over-year net asset growth across 21 annual reporting periods from 2005 to 2025. The most recent momentum reading is +9.8%, with net assets of Rs19.51 Billion INR as of March 2025. See GLAXO total equity for net asset value and shareholders' equity analysis.
GlaxoSmithKline Pharmaceuticals Limited Net Asset Momentum by Year (2005–2025)
GlaxoSmithKline Pharmaceuticals Limited net asset momentum by year from 2005 to 2025. The table below shows the complete annual net asset history for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025, covering 21 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see GlaxoSmithKline Pharmaceuticals Limited market cap and net worth.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Rs19.51 Billion | Rs41.08 Billion | Rs21.57 Billion | ▲ +9.8% |
| 2024 | Rs17.78 Billion | Rs35.57 Billion | Rs17.79 Billion | ▲ +2.1% |
| 2023 | Rs17.41 Billion | Rs33.27 Billion | Rs15.85 Billion | ▼ -34.6% |
| 2022 | Rs26.63 Billion | Rs46.33 Billion | Rs19.70 Billion | ▲ +77.6% |
| 2021 | Rs14.99 Billion | Rs31.13 Billion | Rs16.14 Billion | ▼ -17.7% |
| 2020 | Rs18.21 Billion | Rs31.36 Billion | Rs13.15 Billion | ▼ -14.9% |
| 2019 | Rs21.40 Billion | Rs39.11 Billion | Rs17.71 Billion | ▲ +4.0% |
| 2018 | Rs20.57 Billion | Rs39.47 Billion | Rs18.90 Billion | ▲ +2.5% |
| 2017 | Rs20.07 Billion | Rs30.04 Billion | Rs9.97 Billion | ▲ +18.3% |
| 2016 | Rs16.96 Billion | Rs30.46 Billion | Rs13.50 Billion | ▼ -30.6% |
| 2015 | Rs24.44 Billion | Rs32.24 Billion | Rs7.80 Billion | ▲ +22.8% |
| 2014 | Rs19.90 Billion | Rs31.30 Billion | Rs11.40 Billion | ▼ -0.9% |
| 2013 | Rs20.07 Billion | Rs30.88 Billion | Rs10.82 Billion | ▲ +3.7% |
| 2012 | Rs19.36 Billion | Rs30.66 Billion | Rs11.30 Billion | ▼ -0.8% |
| 2011 | Rs19.52 Billion | Rs28.10 Billion | Rs8.59 Billion | ▲ +9.3% |
| 2010 | Rs17.86 Billion | Rs24.98 Billion | Rs7.12 Billion | ▲ +13.4% |
| 2009 | Rs15.76 Billion | Rs23.21 Billion | Rs7.45 Billion | ▲ +14.1% |
| 2008 | Rs13.81 Billion | Rs20.36 Billion | Rs6.55 Billion | ▲ +14.6% |
| 2007 | Rs12.05 Billion | Rs17.89 Billion | Rs5.84 Billion | ▲ +26.4% |
| 2006 | Rs9.53 Billion | Rs15.16 Billion | Rs5.63 Billion | ▲ +3.2% |
| 2005 | Rs9.24 Billion | Rs14.14 Billion | Rs4.90 Billion | — |